195 related articles for article (PubMed ID: 30632650)
1. C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level.
Yan S; Chen W; Peng C; Zhu W; Chen M; Zhang J; Su J; Li F; Liu Z; Zhang W; Li Q; Li J; Chen X
Exp Dermatol; 2019 Mar; 28(3):240-246. PubMed ID: 30632650
[TBL] [Abstract][Full Text] [Related]
2. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
[TBL] [Abstract][Full Text] [Related]
3. Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.
Guo A; Zhu W; Zhang C; Wen S; Chen X; Chen M; Zhang J; Su J; Chen W; Zhao Y; Yan S; He Y; Liu Z; Zhou H; Chen X; Li J
Arch Dermatol Res; 2015 Mar; 307(2):183-90. PubMed ID: 25412950
[TBL] [Abstract][Full Text] [Related]
4. CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients.
Maouia A; Youssef M; Leban N; Ben Chibani J; Helal AN; Kassab A
Cutan Ocul Toxicol; 2017 Dec; 36(4):387-392. PubMed ID: 28351163
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
Kolkhir P; Altrichter S; Hawro T; Maurer M
Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
[TBL] [Abstract][Full Text] [Related]
6. [Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria].
Yan J; Li Q; Luo Y; Yan S; He Y; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Sep; 43(9):929-936. PubMed ID: 30333282
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
8. Increased serum soluble vascular endothelial cadherin levels in patients with chronic spontaneous urticaria.
Chen T; Guo ZP; Wang WJ; Fu LX; Sun QM; Zhou PM
Ann Allergy Asthma Immunol; 2017 Jun; 118(6):704-709. PubMed ID: 28583263
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
10. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
Leynadier F; Duarte-Risselin C; Murrieta M
Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
[TBL] [Abstract][Full Text] [Related]
11.
Brzoza Z; Rymarczyk B; Grzeszczak W; Trautsolt W; Pluta-Kubicz M; Moczulski D
J Interferon Cytokine Res; 2020 Oct; 40(10):497-500. PubMed ID: 33064598
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
[TBL] [Abstract][Full Text] [Related]
13. Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.
Li J; Chen W; Peng C; Zhu W; Liu Z; Zhang W; Su J; Li J; Chen X
Pharmacogenomics J; 2020 Feb; 20(1):87-93. PubMed ID: 31406237
[TBL] [Abstract][Full Text] [Related]
14. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
[TBL] [Abstract][Full Text] [Related]
15. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
16. Effects of the immunoglobulin/histamine complex on panic disorder concurrent with chronic spontaneous urticaria: a case report.
Kim HS; Noh G
J Med Case Rep; 2023 Jul; 17(1):341. PubMed ID: 37501211
[TBL] [Abstract][Full Text] [Related]
17. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
[TBL] [Abstract][Full Text] [Related]
18. Serum Human β-Defensin 2 Is Increased in Angioedema Accompanying Chronic Spontaneous Urticaria.
Tra Cao TB; Cha HY; Yang EM; Choi BY; Park HS; Ye YM
Int Arch Allergy Immunol; 2021; 182(11):1066-1071. PubMed ID: 34139696
[TBL] [Abstract][Full Text] [Related]
19. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.
Lorette G; Giannetti A; Pereira RS; Leynadier F; Murrieta-Aguttes M
J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):83-90. PubMed ID: 10972091
[TBL] [Abstract][Full Text] [Related]
20. Plasma-Derived Exosomes in Chronic Spontaneous Urticaria Induce the Production of Mediators by Human Mast Cells.
Fang X; Li M; He C; Liu Q; Li J
J Invest Dermatol; 2022 Nov; 142(11):2998-3008.e5. PubMed ID: 35659940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
